Filing Details

Accession Number:
0001246360-11-002636
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-05-24 19:00:15
Reporting Period:
2011-05-20
Filing Date:
2011-05-24
Accepted Time:
2011-05-24 18:00:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
859368 Medicis Pharmaceutical Corp MRX Pharmaceutical Preparations (2834) 521574808
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1173479 Jr G Arthur Altschul 7720 N. Dobson Rd.
Scottsdale AZ 85256
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-20 7,100 $24.99 13,286 No 4 M Direct
Common Stock Disposition 2011-05-20 7,100 $37.04 6,186 No 4 S Direct
Common Stock Acquisiton 2011-05-23 13,900 $24.99 20,086 No 4 M Direct
Common Stock Disposition 2011-05-23 13,900 $36.78 6,186 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Employee Director Option Disposition 2011-05-20 7,100 $0.00 7,100 $24.99
Common Stock Non-Employee Director Option Disposition 2011-05-23 13,900 $0.00 13,900 $24.99
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,900 2002-09-28 2011-09-28 No 4 M Direct
0 2002-09-28 2011-09-28 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.75 to $37.06, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.74 to $36.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.